Regulatory B cells in cancer.

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Tumorigenesis involves genetic alterations and microenvironmental changes driving cancer growth and metastasis.
• Tumor-infiltrating immune cells significantly influence tumor progression and immune suppression.
• Regulatory B cells (Bregs) are increasingly recognized for their role in immune regulation within the tumor microenvironment.

Purpose of the Study:

• To review the history and current understanding of regulatory B cells in cancer.
• To summarize recent research on the mechanistic insights into B cell-mediated immune regulation in cancer.
• To discuss the potential of Bregs as therapeutic targets in solid cancers.

Main Methods:

• Review of existing literature and recent studies on regulatory B cells in cancer.
• Elaboration on genetic models developed for studying Bregs.
• Summary of research on Bregs' functional roles and therapeutic potential.

Main Results:

• B cells can both promote and inhibit immune responses in cancer.
• Regulatory B cells (Bregs) mediate immune suppression through cytokine production, impacting anti-tumor immunity.
• The signals driving Breg expansion and their diverse functions remain areas of active investigation.

Conclusions:

• Regulatory B cells play a significant role in cancer immune evasion and progression.
• Genetic models are advancing the study of Bregs and their functions.
• Targeting regulatory B cells presents a potential therapeutic strategy for solid cancers.